Lockheed Martin is in a clear intermediate-term downtrend despite a still-positive 1-year return of +11.36%, with the current price of $524.19 sitting just 33.1% above the 52-week low of $437.25 and a full 24.3% below the 52-week high of $692.00. That places the stock at roughly 33% of its 52-week range — near the lower quartile — which signals a market that has de-rated the shares aggressively rather than rewarding momentum. The 6-month change of -18.86% versus a +15.40% gain for SPY (a -34.26% relative strength gap) confirms this is severe underperformance, not merely a market-wide pullback, and the -27.35% max drawdown underscores how punishing the decline has been for holders. The practical implication is that this is a falling-knife setup until proven otherwise: value-oriented buyers may see opportunity, but trend-followers should demand evidence of stabilization before committing capital.

Recent momentum is decisively negative and accelerating to the downside: the 1-month change of -13.60% is far worse than the 3-month change of -2.99%, meaning the selloff has intensified in the last several weeks rather than abating. This 1-month figure also badly lags SPY's -1.06% over the same period, producing a -12.54% relative strength reading that shows the weakness is idiosyncratic to Lockheed rather than macro-driven. The divergence between the positive 1-year return (+11.36%) and the sharply negative 1-month and 6-month readings (-13.60% and -18.86%) is a classic late-cycle trend-reversal signal — the stock gave back most of its gains in a compressed window, which typically reflects a fundamental catalyst (earnings quality, guidance, or program concerns) rather than simple mean reversion. Volume of 986,693 on the latest session is modest, suggesting the decline is not yet a capitulation event, and no RSI data was provided to confirm oversold conditions.

Key technical levels are well defined: support sits at the 52-week low of $437.25, roughly 16.6% below the current $524.19, while resistance is anchored at the 52-week high of $692.00, about 32.0% above the current price. A breakdown below $437.25 would signal that the market is pricing in a genuine deterioration in the defense demand or margin story, potentially opening a deeper leg lower; conversely, reclaiming and holding above the $560–$580 zone (the August consolidation area) would be the first evidence of a durable bottom. The reported beta of 0.104 is strikingly low — implying roughly 90% less volatility than the market — which is unusual for a single stock and likely reflects a data anomaly or a calculation based on an atypical window; if taken at face value it would suggest very low systematic risk, but the -27.35% max drawdown and -13.60% monthly move argue the stock is anything but low-risk in practice, so position sizing should rely on realized volatility rather than this beta figure.

Fundamentally, revenue growth has essentially stalled: Q1 2026 revenue of $18.02 billion grew just 0.32% year-over-year, a dramatic deceleration from the $20.33 billion reported in Q4 2025 and the $18.61 billion in Q3 2025. The multi-quarter trend shows revenue oscillating in a narrow $18.0–$20.3 billion band with no clear upward trajectory, and the segment mix — Aeronautics at $6.95 billion, Rotary and Mission Systems at $3.99 billion, Missiles and Fire Control at $3.65 billion, and Space at $3.43 billion — reveals that the F-35-heavy Aeronautics segment remains the dominant driver while the other three segments collectively contribute roughly $11.1 billion. For a company trading at a premium defense multiple, flat top-line growth is a meaningful problem because it means the investment case depends entirely on margin expansion and backlog conversion rather than volume. The 3.2x book-to-bill ratio cited in recent coverage is the key offsetting positive, suggesting future revenue recognition could accelerate if program execution holds.

Profitability is solid but volatile: Q1 2026 net income of $1.488 billion on $18.02 billion of revenue produced a net margin of 8.26%, while the gross margin of 11.53% and operating margin of 11.45% are consistent with Lockheed's historical range but thin in absolute terms. The quarterly progression is choppy — Q3 2025 delivered $1.619 billion of net income at a 12.04% gross margin, Q2 2025 collapsed to just $342 million of net income at a 4.04% gross margin (likely reflecting a program charge), and Q4 2025 recovered to $1.344 billion at an 11.42% gross margin. This pattern of periodic margin shocks is characteristic of defense contractors exposed to fixed-price development programs, and the Q2 2025 gross margin of 4.04% versus the Q1 2026 reading of 11.53% illustrates how violently earnings can swing. The trailing net margin of 6.68% and operating margin of 10.30% confirm that profitability, while positive, is well below what a premium-multiple stock would ideally command.

The balance sheet carries meaningful leverage: debt-to-equity of 3.23 is high, the current ratio of 1.087 is barely above 1.0, and ROE of 74.65% is inflated by that leverage rather than by exceptional capital efficiency. Free cash flow tells a more concerning story — Q1 2026 FCF was negative $291 million (operating cash flow of just $220 million against $511 million of capex), a sharp reversal from Q4 2025's $2.756 billion and Q3 2025's $3.347 billion, though the TTM FCF figure of $5.662 billion remains healthy. The company returned $816 million in dividends and repaid $1.0 billion of debt in Q1 2026 while cash fell from $4.121 billion to $1.894 billion, and with a payout ratio of 62.4% and dividend yield of 2.80%, the dividend looks covered on a TTM basis but vulnerable if quarterly cash generation remains weak. The combination of high leverage, thin liquidity, and lumpy FCF means Lockheed depends on consistent program milestone payments to fund its capital return program.

With net income positive at $1.488 billion, the PE ratio is the appropriate primary metric, and Lockheed trades at a trailing PE of 22.43x versus a forward PE of 16.02x — a 28.6% compression that implies the market expects meaningful earnings growth, consistent with the analyst consensus EPS estimate of $40.60. The gap between trailing and forward multiples is the single most important valuation signal here: it tells us the market is pricing in a substantial earnings recovery, and if that recovery fails to materialize, the stock's current price is not supported by trailing fundamentals. The PEG ratio of -6.05 is not meaningful given the negative earnings growth base, and the PS ratio of 1.49 and EV/Sales of 1.81 are more useful cross-checks for a capital-intensive defense contractor.

Relative to the broader Industrials and Aerospace & Defense sector, Lockheed's 22.43x trailing PE and 16.02x forward PE sit in a middle-to-premium band, while the PB ratio of 16.62x is exceptionally high and reflects the leveraged capital structure rather than a rich asset valuation. The EV/EBITDA of 16.67x is the more telling figure — it is a premium multiple for a company with 0.32% revenue growth and 6.68% net margins, and it implies the market is capitalizing the backlog and future F-35 modernization revenue rather than current cash earnings. The dividend yield of 2.80% is above the sector average and provides some valuation support, but the 62.4% payout ratio limits the cushion if earnings disappoint. On balance, Lockheed looks fairly valued to modestly expensive on forward earnings but expensive on asset-based and EBITDA metrics, leaving little margin of safety.

Historically, Lockheed's PE has ranged from roughly 11.8x (Q4 2021) to 90.4x (Q2 2022, distorted by a charge), with the more normal band sitting between 15x and 23x over the past several years; the current 22.43x trailing PE is therefore near the top of its normalized historical range. The PS ratio of 1.49 is distorted by the data source's inconsistent historical PS readings (which ranged from 5.5x to 8.1x), but the PB ratio of 16.62x is near the high end of its own history and reflects both leverage and the recent de-rating in book value terms. The forward PE of 16.02x, by contrast, sits near the lower end of the historical band, which is the crux of the bull case: if earnings normalize as analysts expect, the stock is cheap on forward numbers even after the recent decline. The risk is that the market is correctly anticipating that the forward estimates are too optimistic, in which case the trailing multiple near historical highs is the more honest signal.

Coverage is robust with 19 analysts, and the consensus recommendation is "buy" with a recommendation mean of 2.43 (on a scale where lower is more bullish), indicating a moderately bullish but not euphoric stance. The average target price of $637.84 implies +21.7% upside from the current $524.19, a meaningful gap that suggests the selloff has outrun analyst fundamental views. The consensus EPS estimate of $40.60 (range $38.78–$41.97) and revenue estimate of $96.18 billion (range $92.86–$98.67 billion) imply analysts expect growth to resume, which is the key assumption underpinning the bullish targets.

The target range spans $503.00 to $756.00 — a 50.3% spread from low to high — which signals unusually high uncertainty about Lockheed's trajectory. The high target of $756.00 assumes multiple expansion and successful conversion of the 3.2x book-to-bill backlog into revenue, while the low target of $503.00 (just 4.0% below the current price) prices in margin compression and program execution risk. Recent institutional actions are mixed but lean constructive: Citigroup upgraded to Buy from Neutral on July 1, 2026, while TD Cowen maintained Hold on July 13, 2026, and RBC Capital, Morgan Stanley, and Jefferies all stayed neutral or hold-rated through April. The pattern of one upgrade against a backdrop of holds suggests analysts are warming to the story but waiting for evidence that the cash-flow and margin issues are resolved before turning decisively bullish.